US20070044813A1 - Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy - Google Patents
Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy Download PDFInfo
- Publication number
- US20070044813A1 US20070044813A1 US11/508,265 US50826506A US2007044813A1 US 20070044813 A1 US20070044813 A1 US 20070044813A1 US 50826506 A US50826506 A US 50826506A US 2007044813 A1 US2007044813 A1 US 2007044813A1
- Authority
- US
- United States
- Prior art keywords
- allergy
- snuff
- preparation
- leaves
- house dust
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Definitions
- the present application relates to the use of an (aqueous) preparation derived from leaves of Nicotiana tabacum , in particular a tobacco extract, ground tobacco leaves or snuff, more in particular snuff, for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy, in particular house dust mite allergy. It also relates to a method for treating house dust mite allergy and/or cigarette smoke allergy, in particular house dust mite allergy, said method including the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum , in particular a tobacco extract, ground tobacco leaves or snuff, more in particular snuff.
- House dust mite allergy and cigarette smoke allergy are characterised by one or more of the following symptoms: watering eyes, an itchy nose and palate, a stuffed up nose, snoring.
- Such allergies are often treated with conventional medicament such as desloratadine and fexofenadine hydrochloride.
- medicaments control the symptoms only partly and often cause alleviation of the symptoms of around 40%.
- Snuff is a well-known stimulant that has been used for centuries.
- a method for its preparation is as follows: After undergoing several maturation processes, the tobacco leave is ground to a silk-like powder. Then the powder is sieved to obtain an even and smooth powder. Users snuff this powder for a pleasant and stimulating experience.
- the present invention relates to a method for treating house dust mite allergy and/or cigarette smoke allergy, said method comprising the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum.
- the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy.
- the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy.
- the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of cigarette smoke allergy.
- one-teaspoon snuff was taken into 100 ml sterile water.
- Sterile water may be obtained commercially or can simply be prepared, for example by boiling tap water.
- the resultant was adminstered once a day, 3 drops per nostril, during 2 weeks. Using such preparation and administration regime, the intended result was achieved, and all of the above symptoms of house dust mite allergy and/or cigarette smoke allergy disappeared.
- the aqueous preparation may be any aqueous preparation that is physiologically acceptably, and is preferably sterile.
- sterile water was used to prepare the aqueous preparation.
- Sterile saline solutions in particular physiological saline solutions, may also be used.
- the aqueous preparation may comprise pharmaceutically acceptable auxiliaries, such as buffer, dispergants, and the like. The skilled practitioner will be aware of suitable aqueous preparations and auxiliaries.
- the term “derived from leaves of Nicotiana tabacum ” refers to a product that is derived from leaves of Nicotiana tabacum .
- the preparation may comprise a product that is obtained by extracting the leaves of the tobacco plant Nicotiana tabacum , gring of such leaves, or the like. Any product that can be incorporated in an aqueous preparation and can be administered intranasallly is suitable for incorporation in the aqueous preparation according to the present invention.
- the preparation comprises a product chosen from the group consisting of tobacco extract, ground tobacco leaves and snuff.
- tobacco extract ground tobacco leaves and snuff.
- the effectivity of snuff has been demonstrated, and it is expected that the invention will similarly be applicable to preparations comprising tobacco extract and/or ground tobacco leaves.
- the product is snuff, since snuff has been found to yield the intended result.
- the aqueous product may, in particular in the case of snuff, be prepared just prior to it application by adding 1-10 grams, preferably 2-7 grams, more preferably 3-5 grams, to 50-150 ml, preferably about 75-125 ml, water or aqueous solution.
- the aqueous preparation according to the present invention is administered during 1 week, preferably 2 weeks.
- the administration regime is preferably once a day administration of the above aqueous preparation, 2-5, preferably about 3, drops a day.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy. The preparation may comprise tobacco extract, ground tobacco leaves or snuff. In a preferred embodiment, the aqueous preparation is a preparation of snuff dispersed in water or an aqueous solution.
Description
- The present application claims the benefit of Netherlands application number 1029798 filed Aug. 24, 2005, the contents of which are incorporated by reference herein.
- The present application relates to the use of an (aqueous) preparation derived from leaves of Nicotiana tabacum, in particular a tobacco extract, ground tobacco leaves or snuff, more in particular snuff, for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy, in particular house dust mite allergy. It also relates to a method for treating house dust mite allergy and/or cigarette smoke allergy, in particular house dust mite allergy, said method including the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum, in particular a tobacco extract, ground tobacco leaves or snuff, more in particular snuff.
- House dust mite allergy and cigarette smoke allergy are characterised by one or more of the following symptoms: watering eyes, an itchy nose and palate, a stuffed up nose, snoring.
- Such allergies are often treated with conventional medicament such as desloratadine and fexofenadine hydrochloride. However, such medicaments control the symptoms only partly and often cause alleviation of the symptoms of around 40%.
- It has now surprisingly been found that daily intranasal administration of an aqueous preparation of snuff during some time resulted in disappearance of the above symptoms. Once the symptoms had disappeared, the therapeutic treatment was stopped. Nevertheless the symptoms did not re-appear for at least one and a half-year, without revering to conventional therapy.
- Snuff is a well-known stimulant that has been used for centuries. A method for its preparation is as follows: After undergoing several maturation processes, the tobacco leave is ground to a silk-like powder. Then the powder is sieved to obtain an even and smooth powder. Users snuff this powder for a pleasant and stimulating experience. A therapeutic use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy, in particular when the snuff is incorporated in an aqueous preparation, has hitherto not been described.
- It is expected that the same effect on house dust mite allergy and/or cigarette smoke allergy as described for snuff will also be achieved using other (aqueous) preparations derived from leaves of Nicotiana tabacum, in particular tobacco extract and ground tobacco leaves. It is expected that the leaves comprise one or more substances that can serve as active ingredient in a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy.
- Also, the present invention relates to a method for treating house dust mite allergy and/or cigarette smoke allergy, said method comprising the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum.
- The present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy.
- In a preferred embodiment, the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy.
- In another embodiment, the present invention relates to the use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of cigarette smoke allergy.
- In the case of snuff, one-teaspoon snuff was taken into 100 ml sterile water. Sterile water may be obtained commercially or can simply be prepared, for example by boiling tap water. The resultant was adminstered once a day, 3 drops per nostril, during 2 weeks. Using such preparation and administration regime, the intended result was achieved, and all of the above symptoms of house dust mite allergy and/or cigarette smoke allergy disappeared.
- The aqueous preparation may be any aqueous preparation that is physiologically acceptably, and is preferably sterile. In the present example, sterile water was used to prepare the aqueous preparation. Sterile saline solutions, in particular physiological saline solutions, may also be used. Further, the aqueous preparation may comprise pharmaceutically acceptable auxiliaries, such as buffer, dispergants, and the like. The skilled practitioner will be aware of suitable aqueous preparations and auxiliaries.
- The term “derived from leaves of Nicotiana tabacum” refers to a product that is derived from leaves of Nicotiana tabacum. For example, the preparation may comprise a product that is obtained by extracting the leaves of the tobacco plant Nicotiana tabacum, gring of such leaves, or the like. Any product that can be incorporated in an aqueous preparation and can be administered intranasallly is suitable for incorporation in the aqueous preparation according to the present invention.
- In a preferred embodiment, the preparation comprises a product chosen from the group consisting of tobacco extract, ground tobacco leaves and snuff. The effectivity of snuff has been demonstrated, and it is expected that the invention will similarly be applicable to preparations comprising tobacco extract and/or ground tobacco leaves.
- In a more preferred embodiment the product is snuff, since snuff has been found to yield the intended result. The aqueous product may, in particular in the case of snuff, be prepared just prior to it application by adding 1-10 grams, preferably 2-7 grams, more preferably 3-5 grams, to 50-150 ml, preferably about 75-125 ml, water or aqueous solution.
- Preferably, the aqueous preparation according to the present invention is administered during 1 week, preferably 2 weeks. The administration regime is preferably once a day administration of the above aqueous preparation, 2-5, preferably about 3, drops a day.
Claims (8)
1. The use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy and/or cigarette smoke allergy.
2. The use of an aqueous preparation derived from leaves of Nicotiana tabacum for the preparation of a medicament for treatment of house dust mite allergy.
3. Use according to claim 1 , the preparation comprising a product chosen from the group consisting of tobacco extract, ground tobacco leaves and snuff.
4. Use according to claim 3 , the product being snuff.
5. A method for treating house dust mite allergy and/or cigarette smoke allergy, said method comprising the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum.
6. A method for treating house dust mite allergy, said method comprising the step of administering to a patient in need thereof an aqueous preparation derived from leaves of Nicotiana tabacum.
7. Method according to claim 5 , the preparation comprising a product chosen from the group consisting of tobacco extract, ground tobacco leaves, and snuff.
8. Method according to claim 7 , the product being snuff.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1029798 | 2005-08-24 | ||
NL1029798A NL1029798C2 (en) | 2005-08-24 | 2005-08-24 | Application of snuff for the treatment of respiratory allergy. |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070044813A1 true US20070044813A1 (en) | 2007-03-01 |
Family
ID=37802338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/508,265 Abandoned US20070044813A1 (en) | 2005-08-24 | 2006-08-23 | Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy |
Country Status (2)
Country | Link |
---|---|
US (1) | US20070044813A1 (en) |
NL (1) | NL1029798C2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1839970A (en) * | 1924-06-09 | 1932-01-05 | Moorman Mfg Co | Vermifuge medicine and process of producing same |
US4261981A (en) * | 1980-01-28 | 1981-04-14 | Sam Humphrey | Medical compound produced from ragweed |
US4579858A (en) * | 1983-01-21 | 1986-04-01 | Aktiebolaget Leo | Smoking substitutes for nasal administration-I |
-
2005
- 2005-08-24 NL NL1029798A patent/NL1029798C2/en not_active IP Right Cessation
-
2006
- 2006-08-23 US US11/508,265 patent/US20070044813A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1839970A (en) * | 1924-06-09 | 1932-01-05 | Moorman Mfg Co | Vermifuge medicine and process of producing same |
US4261981A (en) * | 1980-01-28 | 1981-04-14 | Sam Humphrey | Medical compound produced from ragweed |
US4579858A (en) * | 1983-01-21 | 1986-04-01 | Aktiebolaget Leo | Smoking substitutes for nasal administration-I |
Also Published As
Publication number | Publication date |
---|---|
NL1029798C2 (en) | 2007-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060062835A1 (en) | Multi-disciplinary nicotine craving reduction kit with potentiating homeopathic elements | |
Josling et al. | Use of cellulose powder for the treatment of seasonal allergic rhinitis | |
AU2009266076A1 (en) | Antiallergic marine biopolymers | |
US20050100513A1 (en) | Homeopathic method and system for treating nicotine addiction | |
US9061052B2 (en) | Aqueous extract of tobacco leaves, its uses in the treatment of dependence | |
US20060210482A1 (en) | Chemical composition and method for cold and sinus relief | |
JP2009536183A5 (en) | ||
US20070044813A1 (en) | Use of snuff for treatment of house dust mite allergy and/or cigarette smoke allergy | |
CA3014725C (en) | Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists | |
US9226944B2 (en) | Herbal preparation for sleep apnea relief | |
CA2506962A1 (en) | Synergistic combination comprising roflumilast and formoterol | |
NL1032360C2 (en) | Aqueous snuff preparation for treating e.g. house dust mite allergy, has tobacco extract and ground tobacco leaves or snuff, where preparation is derived from leaves of Nicotiana tabacum | |
US20220132882A1 (en) | Herbal Tea Products and Methods | |
US10966988B2 (en) | Method for smoking cessation | |
EP2593119B1 (en) | Polysaccharide polymer from the seeds of the tamarind tree for use in treating dry cough | |
TW202310855A (en) | Treatment of covid-19 and other viral infections, bacterial infections, injuries, ards, or conditions that result in acute elevation of substance p levels causing pathological activation of the cytokine system using nitrous oxide or any of the inhaled anesthetics | |
CN116322733A (en) | Phytotherapeutic compositions | |
RU2146942C1 (en) | Method of treatment of tobacco smoking | |
KR20230046905A (en) | Respiratory Disease Treatment | |
US20210220371A1 (en) | Method for smoking cessation | |
JP2022104569A (en) | Drug and infectious disease prevention sheet and mask | |
WO2019162959A1 (en) | A medicinal formulation for treatment of cough, sore throat and throat infection | |
NZ787061A (en) | Compositions and methods for treating nasal and paranasal mucosa diseases with | |
US8399031B1 (en) | Compositions and methods for restoring pulmonary function | |
US20020088470A1 (en) | Method and composition for reducing the tobacco consumption of a human while freshening the breath from tobacco odors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |